Eli Lilly and Company
CL ˙ SNSE ˙ US5324571083
SecurityCL:LLY / Eli Lilly and Company
InstitutionImpax Asset Management Group plc
Latest Disclosed Ownership39,319 shares
Latest Disclosed Value $ 36,164,437
Impax Asset Management Group plc reports 14.02% decrease in ownership of LLY / Eli Lilly and Company

On May 12, 2026 - Impax Asset Management Group plc filed a 13F-HR form disclosing ownership of 39,319 shares of Eli Lilly and Company (CL:LLY) valued at $36,164,437 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 29, 2026 disclosing 45,731 shares of Eli Lilly and Company. This represents a change in shares of -14.02% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-12 2026-03-31 13F Eli Lilly Common Stock 532457108 39,319 -6,412 -14.02 36,164 -26.42 0.2521
2026-01-29 2025-12-31 13F Eli Lilly Common Stock 532457108 45,731 -13,598 -22.92 49,146 8.57 0.3075
2025-11-06 2025-09-30 13F Eli Lilly Common Stock 532457108 59,329 -9,912 -14.32 45,268 -16.13 0.2642
2025-08-08 2025-06-30 13F Eli Lilly Common Stock 532457108 69,241 7,803 12.70 53,975 6.37 0.3103
2025-04-29 2025-03-31 13F Eli Lilly Common Stock 532457108 61,438 14,876 31.95 50,742 41.17 0.3056
2025-02-04 2024-12-31 13F Eli Lilly Common Stock 532457108 46,562 25,167 117.63 35,946 89.64 0.1628
2024-11-06 2024-09-30 13F/A-1 Eli Lilly Common Stock 532457108 21,395 -566 -2.58 18,955 -4.67 0.0746
2024-10-30 2024-09-30 13F Eli Lilly Common Stock 532457108 21,395 -566 18,955 0.0747
2024-11-08 2024-06-30 13F/A-1 Eli Lilly Common Stock 532457108 21,961 -5,927 -21.25 19,883 -8.35 0.0809
2024-08-05 2024-06-30 13F Eli Lilly Common Stock 532457108 21,961 -5,927 19,883 0.0810
2024-04-30 2024-03-31 13F Eli Lilly Common Stock 532457108 27,888 -2,380 -7.86 21,696 22.97 0.0830
2024-01-26 2023-12-31 13F Eli Lilly Common Stock 532457108 30,268 1,560 5.43 17,644 14.42 0.0708
2023-11-07 2023-09-30 13F/A-1 Eli Lilly Common Stock 532457108 28,708 -2,181 -7.06 15,420 6.44 0.0689
2023-11-07 2023-09-30 13F Eli Lilly Common Stock 532457108 28,708 15,420
2023-08-07 2023-06-30 13F Eli Lilly Common Stock 532457108 30,889 79 0.26 14,486 36.92 0.0582
2023-05-10 2023-03-31 13F Eli Lilly Common Stock 532457108 30,810 -1,373 -4.27 10,581 -10.13 0.0442
2023-02-09 2022-12-31 13F Eli Lilly Common Stock 532457108 32,183 -4,089 -11.27 11,774 0.38 0.0527
2022-11-08 2022-09-30 13F Eli Lilly Common Stock 532457108 36,272 -1,356 -3.60 11,729 -3.86 0.0603
2022-08-11 2022-06-30 13F/A-2 Eli Lilly Common Stock 532457108 37,628 -575 -1.51 12,200 11.52 0.0595
2022-08-02 2022-06-30 13F Eli Lilly Common Stock 532457108 38,203 0 10,940 0.0452
2022-05-16 2022-03-31 13F Eli Lilly Common Stock 532457108 38,203 -1,609 -4.04 10,940 -0.51 0.0452
2022-02-14 2021-12-31 13F Eli Lilly Common Stock 532457108 39,812 -1,463 -3.54 10,996 15.30 0.0402
2021-11-12 2021-09-30 13F Eli Lilly Common Stock 532457108 41,275 75 0.18 9,537 0.86 0.0392
2021-08-05 2021-06-30 13F Eli Lilly Common Stock 532457108 41,200 -4 -0.01 9,456 22.84 0.0417
2021-05-14 2021-03-31 13F Eli Lilly and Common Stock 532457108 41,204 15,089 57.78 7,698 74.60 0.0394
2021-02-16 2020-12-31 13F Eli Lilly and Common Stock 532457108 26,115 -8,160 -23.81 4,409 -13.09 0.0281
2020-11-12 2020-09-30 13F Eli Lilly and Common Stock 532457108 34,275 11,184 48.43 5,073 33.82 0.0444
2020-08-14 2020-06-30 13F Eli Lilly and Common Stock 532457108 23,091 499 2.21 3,791 20.96 0.0389
2020-05-15 2020-03-31 13F Eli Lilly Common Stock 532457108 22,592 3,598 18.94 3,134 25.56 0.0417
2020-02-13 2019-12-31 13F Eli Lilly Common Stock 532457108 18,994 1,678 9.69 2,496 28.93 0.0278
2019-11-14 2019-09-30 13F Eli Lilly Common Stock 532457108 17,316 1,424 8.96 1,936 9.94 0.0252
2019-08-13 2019-06-30 13F Eli Lilly Common Stock 532457108 15,892 416 2.69 1,761 -12.30 0.0229
2019-05-13 2019-03-31 13F Eli Lilly Common Stock 532457108 15,476 -143,318 -90.25 2,008 -89.07 0.0276
2019-02-14 2018-12-31 13F Eli Lilly Common Stock 532457108 158,794 -26,721 -14.40 18,376 -7.70 0.2995
2018-11-14 2018-09-30 13F Eli Lilly Common Stock 532457108 185,515 185,515 19,908 0.2859
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.